Prime Medicine, Inc. Common Stock (PRME) — Financial Flexibility Index
Prime Medicine, Inc. Common Stock (PRME) has a Financial Flexibility Index of -0.20x as of June 2026. Free cash flow of $-41.00 Million (operating CF $-41.05 Million minus capex $46.00K) represents 0% of total liabilities ($209.23 Million). Check total reinvestment intensity of Prime Medicine, Inc. Common Stock to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Prime Medicine, Inc. Common Stock Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Prime Medicine, Inc. Common Stock across 7 annual periods. For the full cash flow conversion analysis, see PRME cash flow conversion.
Annual Financial Flexibility Index for Prime Medicine, Inc. Common Stock (2019–2025)
Year-by-year free cash flow to debt coverage for Prime Medicine, Inc. Common Stock. Explore Prime Medicine, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.71x | $-158.03 Million | $-162.56 Million | $221.87 Million | ▲ +11.0% |
| 2024 | -0.80x | $-115.57 Million | $-122.86 Million | $144.36 Million | ▲ +68.9% |
| 2023 | -2.58x | $-156.69 Million | $-165.41 Million | $60.78 Million | ▲ +1.9% |
| 2022 | -2.63x | $-115.73 Million | $-131.83 Million | $44.04 Million | ▼ -446.9% |
| 2021 | -0.48x | $-29.93 Million | $-34.08 Million | $62.30 Million | ▼ -108.7% |
| 2020 | -0.23x | $-4.91 Million | $-5.54 Million | $21.31 Million | ▼ -142.0% |
| 2019 | -0.10x | $-695.00K | $-1.33 Million | $7.31 Million | — |